Magnetic Resonance Imaging and Spectroscopy of the Prostate
Completed
- Conditions
- Prostate Cancer
- Interventions
- Other: MRI and MRSI
- Registration Number
- NCT00590993
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 1005
Inclusion Criteria
- prostate cancer patients willing to undergo a MRI and MRSI exam
Read More
Exclusion Criteria
- patients with prostate cancer and bone or lymph node metastasis
- patients who can not have an MRI exam
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 - MRSI / MRI MRI and MRSI -
- Primary Outcome Measures
Name Time Method Determine added value in combining MRSI and MRI in prostate cancer treatment 3 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States